IDEA - Investigating Dupilumab's Effect in Asthma by Genotype

National Institute of Allergy and Infectous Diseases

Do you have asthma?

What if there was a way to reduce your asthma symptoms? Researchers are studying whether Dupixent® can help bad asthma and reduce asthma symptoms.

In this research study we want to learn if Dupixent® (Dupilumab) helps to control your asthma. We are particularly interested in understanding if people who have a certain genetic make-up (genotype) will respond better to this treatment.

Study participants receive breathing symptom management by study doctors as well as respiratory symptom medication at no cost. If you are 12 years and above, you may be eligible to participate in this clinical study.

The IDEA study is being conducted across the U.S. at the following locations:

Boston Children's Hospital
Boston, MA
Asthma Clinical Research Center
(857) 218-5531
asthma@childrens.harvard.edu
Atlantic Respiratory Institute
Summit, NJ
Beverly Obispo
(908) 934-0555 ext 78625
Beverly.Obispo@atlantichealth.org
Brigham & Women's Hospital
Boston, MA
Angeles Cinelli
(617) 732-8201
mcinelli@bwh.harvard.edu
Henry Ford Health System
Detroit, MI
Sherae Hereford
(313) 916-6940
sherefo3@hfhs.org

Contact
Us Now

to learn more about
participating in the
IDEA study

857-218-5336
asthma@childrens.harvard.edu

Contact
Us Now

to learn more about
participating in the
IDEA study

857-218-5336
asthma@childrens.harvard.edu